BIO India to Spur Cross-Border Collaborations and Partnership Deals
Washington, D.C. and Mumbai, India (August 22, 2012)–The Biotechnology Industry Organization (BIO) today announces the initial selection of presenting companies for the 3rd Annual BIO India International Conference, September 12-13 at the Grand Hyatt in Mumbai, India. Through company presentations and partnering opportunities available at the BIO India event, attendees will be able to connect with other industry leaders to discuss potential collaborations and deals.
BIO brings to India more than ten years experience and expertise in biotechnology and pharmaceutical partnering. BIO is renowned for its successful partnering meetings held around the globe, including the industry’s largest partnering event – the BIO Business Forum at the BIO International Convention.
“BIO India is a unique event that allows biotech and pharmaceutical leaders from around the world to gather and explore potential partnerships and collaborations with India’s life science companies. It is our hope that attendees and presenters alike capitalize on the exceptional opportunities available only at this event,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.
BIO India will once again feature company presentations by biotech and pharmaceutical companies. Last year's conference attracted over 320 attendees representing 200 companies from 15 countries around the world. Presenting companies receive increased visibility prior to and during the conference to BIO members and event attendees, as well as access to the One-on-One Partnering™ system. To apply to present at BIO India, click here.
As of today, the following companies are scheduled to present at this year’s event:
- Clinigene International Ltd(A Biocon Company)
- Debiopharm Group
- Genotypic Technology Private Limited
- Health Protection Agency
- Indus Biotech Pvt Ltd
- Kemwell Biopharma Pvt Ltd
- Mitra Biotech Pvt Ltd
- MSD Wellcome Trust Hilleman Laboratories
- Novo Nordisk
- Piramal Life Sciences Limited
- PRAJ Industries Ltd
- Richcore Lifesciences Pvt Ltd
- SGS M-Scan
- Shantani Proteome Analytics Pvt Ltd
- Spectrum Pharmaceuticals, Inc.
- Stempeutics Research Pvt Ltd
- Zydus Cadila
India’s biotech and pharmaceutical space is world class, and the number and type of collaborations between Indian and US or EU companies has grown rapidly in the past few years. Event attendees will have the opportunity to connect with industry leaders through BIO’s One-on-One Partnering™system to 30-minute meetingsin private rooms provided by BIO onsite atthe conference. This industry-specific, web-based interactive software enables participants to move efficiently from the identification of prospective partners to discussion and negotiations. To learn more about the system, including its evolution, read here.
Through this conference and ongoing advocacy efforts, BIO aims to help the industry flourish within India's borders and help patients and citizens benefit from the promise of biotech. BIO has partnered with the Association of Biotechnology Led Enterprises (ABLE), which represents Indian and Asian biotechnology and pharmaceutical companies, as well as leading investment banks and Venture Capital firms.